← All Sponsors
SPONSOR

University of Calgary

Total Trials
17
Recruiting
17
Phases
Phase 2, Phase 3

University of Calgary is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Alcohol Use Disorder, Alcoholism, Sickle Cell Disease, Stem Cell Transplant Complications.

The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Calgary

How many clinical trials has University of Calgary sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by University of Calgary, of which 17 are actively recruiting participants. These trials cover conditions including Alcohol Use Disorder, Alcoholism, Sickle Cell Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Calgary research focus on?
University of Calgary clinical trials span Alcohol Use Disorder, Alcoholism, Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Calgary clinical trial?
To participate in a University of Calgary trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Calgary trials with current recruitment status updated daily.

Clinical Trials by University of Calgary

NCT05995769 Phase 2
Recruiting

Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder

Alcohol Use Disorder
NCT03214354 Phase 2
Recruiting

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Sickle Cell Disease
NCT06160778 Phase 3
Recruiting

Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain

Acute Pain
NCT04186286 Phase 2
Recruiting

Crossover Study of Propranolol vs Ivabradine in POTS

Postural Tachycardia Syndrome
NCT05347875
Recruiting

Implementation of an App-based Walking Aid Skills Training Program

Lower Limb; Sprain (Strain)
NCT04400617
Recruiting

Sleep Quality in Assisted-Living Residents

Sleep Disturbance
NCT04789616 Phase 2
Recruiting

The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke

Stroke
NCT06133374
Recruiting

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

Papillary Thyroid Cancer
NCT06177184
Recruiting

DOnor Milk to REpair the Full-term Infant MIcrobiome in Infants Born Via Cesarean Section.

Microbial Colonization
NCT05775965 Phase 2
Recruiting

HIP Fracture Oral ThromboPROphylaxis (Hip PRO Pilot)

Hip Fractures
NCT06537453
Recruiting

UPTAKE - Virtual Care: Virtual Home Hospital With Remote Monitoring to Reduce Acute Care Hospitalization

Acute Kidney Injury
NCT06221358
Recruiting

Pharmacogenomics of Stimulant Treatment Response

Attention-Deficit/ Hyperactivity Disorder (ADHD)
NCT05159687 Phase 3
Recruiting

Study of Atomoxetine in the Prevention of Vasovagal Syncope

Vasovagal Syncope
NCT05362435
Recruiting

Makoyoh'Sokoi - The Wolf Trail Program Expansion Project - Supporting Indigenous Women to Celebrate Good Health

Physical Inactivity
NCT04956133
Recruiting

IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment

Pediatric Cancer
NCT05106140
Recruiting

Robotic Evaluations of Motor Learning During Stroke Neurorehabilitation

Stroke
NCT05756244
Recruiting

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

Pregnancy Related
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology